Ethics
All participants signed the written informed consent before initiating the study. The study was approved by the Ethics Committee of Shiraz University of Medical Sciences, Shiraz, Iran (registration no. IR.SUMS.REC.1395.22) and was registered at Iranian Registry of Clinical Trials website (IRCT2016050327733N1).
REFRENCES:
1. Woo JG, Guerrero ML, Ruiz-Palacios GM, Peng Y-m, Herbers PM, Yao W, et al. Specific infant feeding practices do not consistently explain variation in anthropometry at age 1 year in urban United States, Mexico, and China cohorts. The Journal of nutrition. 2013;143(2):166-74.
2. Vriz O, Lu H, Visentin P, Nicolosi L, Mos L, Palatini P. Gender differences in the relationship between left ventricular size and ambulatory blood pressure in borderline hypertension. The HARVEST Study. European heart journal. 1997;18(4):664-70.
3. Fukumitsu S, Aida K, Ueno N, Ozawa S, Takahashi Y, Kobori M. Flaxseed lignan attenuates high-fat diet-induced fat accumulation and induces adiponectin expression in mice. British journal of nutrition. 2008;100(03):669-76.
4. Matsuzawa Y, Funahashi T, Nakamura T. Molecular Mechanism of Metabolic Syndrome X: Contribution of Adipocytokines· Adipocyte‐derived Bioactive Substances. Annals of the New York Academy of Sciences. 1999;892(1):146-54.
5. Haluzik M, Parizkova J, Haluzik M. Adiponectin and its role in the obesity-induced insulin resistance and related complications. Physiological Research. 2004;53(2):123-30.
6. Iacobellis G, Pistilli D, Gucciardo M, Leonetti F, Miraldi F, Brancaccio G, et al. Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with coronary artery disease. Cytokine. 2005;29(6):251-5.
7. McCullough RS, Edel AL, Bassett CM, LaVallée RK, Dibrov E, Blackwood DP, et al. The alpha linolenic acid content of flaxseed is associated with an induction of adipose leptin expression. Lipids. 2011;46(11):1043-52.
8. Zhou Y, Rui L. Leptin signaling and leptin resistance. Frontiers of medicine. 2013;7(2):207-22.
9. Beaulieu A, Poncin G, Belaid-Choucair Z, Humblet C, Bogdanovic G, Lognay G, et al. Leptin reverts pro-apoptotic and antiproliferative effects of α-linolenic acids in BCR-ABL positive leukemic cells: involvement of PI3K pathway. PloS one. 2011;6(10):e25651.
10. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. New England Journal of Medicine. 1996;334(5):292-5.
11. Park JB, Velasquez MT. Potential effects of lignan-enriched flaxseed powder on bodyweight, visceral fat, lipid profile, and blood pressure in rats. Fitoterapia. 2012;83(5):941-6.
12. Goyal A, Sharma V, Upadhyay N, Gill S, Sihag M. Flax and flaxseed oil: an ancient medicine & modern functional food. Journal of food science and technology. 2014;51(9):1633-53.
13. Yari Z, Rahimlou M, Poustchi H, Hekmatdoost A. Flaxseed Supplementation in Metabolic Syndrome Management: A Pilot Randomized, Open‐labeled, Controlled Study. Phytotherapy Research. 2016;30(8):1339-44.
14. Daleprane JB, Batista A, Pacheco JT, Da Silva AF, Costa CA, de Castro Resende Â, et al. Dietary flaxseed supplementation improves endothelial function in the mesenteric arterial bed. Food research international. 2010;43(8):2052-6.
15. Yang WS, Lee WJ, Funahashi T, Tanaka S, Matsuzawa Y, Chao CL, Chen CL, Tai TY, Chuang LM. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab. 2001 Aug;86(8):3815-9.
16. Barre D, Mizier-Barre K, Stelmach E, Hobson J, Griscti O, Rudiuk A, et al. Flaxseed lignan complex administration in older human Type 2 diabetics manages central obesity and prothrombosis—an invitation to further investigation into polypharmacy reduction. Journal of nutrition and metabolism. 2012;2012.
17. Blüher S, Mantzoros CS. Leptin in humans: lessons from translational research. The American journal of clinical nutrition. 2009;89(3):991S-7S.
18. Machado AM, de Paula H, Cardoso LD, Costa NM. Effects of brown and golden flaxseed on the lipid profile, glycemia, inflammatory biomarkers, blood pressure and body composition in overweight adolescents. Nutrition. 2015;31(1):90-6.
19. Khalatbari Soltani S, Jamaluddin R, Tabibi H, Yusof M, Nisak B, Atabak S, et al. Effects of flaxseed consumption on systemic inflammation and serum lipid profile in hemodialysis patients with lipid abnormalities. Hemodialysis International. 2013;17(2):275-81.
20. Bloedon LT, Szapary PO. Flaxseed and cardiovascular risk. Nutrition reviews. 2004;62(1):18-27.
21. Pan A, Yu D, Demark-Wahnefried W, Franco OH, Lin X. Meta-analysis of the effects of flaxseed interventions on blood lipids. The American journal of clinical nutrition. 2009;90(2):288-97.
22. Fukumitsu S, Aida K, Shimizu H, Toyoda K. Flaxseed lignan lowers blood cholesterol and decreases liver disease risk factors in moderately hypercholesterolemic men. Nutrition research (New York, NY). 2010;30(7):441-6.
23. Wang, M., Zhang, XJ., Feng, K. et al.  Dietary α-linolenic acid-rich flaxseed oil prevents against alcoholic hepatic steatosis via  ameliorating lipid homeostasis at adipose tissue-liver axis in mice. Sci Rep  6,  26826 (2016).
24. Jump DB, Botolin D, Wang Y, Xu J, Christian B, Demeure O. Fatty acid regulation of hepatic gene transcription. The Journal of nutrition. 2005;135(11):2503-6.
25. Felmlee MA, Woo G, Simko E, Krol ES, Muir AD, Alcorn J. Effects of the flaxseed lignans secoisolariciresinol diglucoside and its aglycone on serum and hepatic lipids in hyperlipidaemic rats. The British journal of nutrition. 2009;102(3):361-9.
26. Park JB, Velasquez MT. Potential effects of lignan-enriched flaxseed powder on bodyweight, visceral fat, lipid profile, and blood pressure in rats. Fitoterapia. 2012;83(5):941-6.
27. Pellizzon MA, Billheimer JT, Bloedon LT, Szapary PO, Rader DJ. Flaxseed reduces plasma cholesterol levels in hypercholesterolemic mouse models. Journal of the American College of Nutrition. 2007;26(1):66-75.
28. Prasad K, Mantha S, Muir A, Westcott N. Reduction of hypercholesterolemic atherosclerosis by CDC-flaxseed with very low alpha-linolenic acid. Atherosclerosis. 1998;136(2):367-75.
29. Cornish SM, Chilibeck PD, Paus-Jennsen L, Biem HJ, Khozani T, Senanayake V, et al. A randomized controlled trial of the effects of flaxseed lignan complex on metabolic syndrome composite score and bone mineral in older adults. Applied Physiology, Nutrition, and Metabolism. 2009;34(2):89-98.
30. Lemay A, Dodin S, Kadri N, Jacques H, Forest J-C. Flaxseed dietary supplement versus hormone replacement therapy in hypercholesterolemic menopausal women. Obstetrics & Gynecology. 2002;100(3):495-504.
31. Nelson TL, Stevens JR, Hickey MS. Adiponectin levels are reduced, independent of polymorphisms in the adiponectin gene, after supplementation with α-linolenic acid among healthy adults. Metabolism. 2007;56(9):1209-15.
32. Dent E, Kowal P, Hoogendijk EO. Frailty measurement in research and clinical practice: A review. European journal of internal medicine. 2016;31:3-10.
33. Mahan LK, Raymond JL. Krause’s Food & the Nutrition Care Process-E-Book: Elsevier Health Sciences; 2016.
34. Park JB, Velasquez MT. Potential effects of lignan-enriched flax seed powder on blood pressure, fat accumulation, and lipid profile in rats. The FASEB Journal. 2011;25(1_MeetingAbstracts):339.6.
35. Wu H, Pan A, Yu Z, Qi Q, Lu L, Zhang G, et al. Lifestyle counseling and supplementation with flaxseed or walnuts influence the management of metabolic syndrome. The Journal of nutrition. 2010;140(11):1937-42.
36. Pineda AMR, Gómez BLG, Alzate CMA, Castaño CFM, Marín BEL. Consumo de linaza molida para la reducción de peso corporal en personas con exceso de peso. Perspectivas en Nutrición Humana. 2011;13(1):56.
37. Taylor CG, Noto AD, Stringer DM, Froese S, Malcolmson L. Dietary milled flaxseed and flaxseed oil improve N-3 fatty acid status and do not affect glycemic control in individuals with well-controlled type 2 diabetes. J Am Coll Nutr. 2010 Feb;29(1):72-80.
38. Prasad K. Reduction of serum cholesterol and hypercholesterolemic atherosclerosis in rabbits by secoisolariciresinol diglucoside isolated from flaxseed. Circulation. 1999;99(10):1355-62.
39. Kratz M, Swarbrick MM, Callahan HS, Matthys CC, Havel PJ, Weigle DS. Effect of dietary n–3 polyunsaturated fatty acids on plasma total and high-molecular-weight adiponectin concentrations in overweight to moderately obese men and women. The American journal of clinical nutrition. 2008;87(2):347-53.
40. Hallund J, Ravn-Haren G, Bügel S, Tholstrup T, Tetens I. A lignan complex isolated from flaxseed does not affect plasma lipid concentrations or antioxidant capacity in healthy postmenopausal women. The Journal of nutrition. 2006;136(1):112-6.
41. Cassani RSL, Fassini PG, Silvah JH, Lima CMM, Marchini JS. Impact of weight loss diet associated with flaxseed on inflammatory markers in men with cardiovascular risk factors: a clinical study. Nutrition journal. 2015;14(1):5.
42. Hutchins AM, Brown BD, Cunnane SC, Domitrovich SG, Adams ER, Bobowiec CE. Daily flaxseed consumption improves glycemic control in obese men and women with pre-diabetes: a randomized study. Nutrition Research. 2013;33(5):367-75.
43. Patel JV, Lee KW, Tomson J, Dubb K, Hughes EA, Lip GY. Effects of omega-3 polyunsaturated fatty acids on metabolically active hormones in patients post-myocardial infarction. International journal of cardiology. 2007;115(1):42-5.
44. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. The Journal of Clinical Endocrinology & Metabolism. 2001;86(5):1930-5.
45. Flachs P, Mohamed-Ali V, Horakova O, Rossmeisl M, Hosseinzadeh-Attar M, Hensler M, et al. Polyunsaturated fatty acids of marine origin induce adiponectin in mice fed a high-fat diet. Diabetologia. 2006;49(2):394-7.
46. Babcock TA, Novak T, Ong E, Jho DH, Helton WS, Espat NJ. Modulation of lipopolysaccharide-stimulated macrophage tumor necrosis factor-α production by ω-3 fatty acid is associated with differential cyclooxygenase-2 protein expression and is independent of interleukin-10. Journal of Surgical Research. 2002;107(1):135-9.
47. José-Manuel Fernández-Real, Joan Vendrell, Wifredo Ricart, Circulating Adiponectin and Plasma Fatty Acid Profile, Clinical Chemistry , Volume 51, Issue 3, 1 March 2005, Pages 603–609.
48. Rosen ED, Walkey CJ, Puigserver P, Spiegelman BM. Transcriptional regulation of adipogenesis. Genes & development. 2000;14(11):1293-307.
49. Hariri M, Ghiasvand R, Shiranian A, Askari G, Iraj B, Salehi‐Abargouei A. Does omega‐3 fatty acids supplementation affect circulating leptin levels? A systematic review and meta‐analysis on randomized controlled clinical trials. Clinical endocrinology. 2015;82(2):221-8.
50. Zhou YE, Kubow S, Dewailly E, Julien P, Egeland GM. Decreased activity of desaturase 5 in association with obesity and insulin resistance aggravates declining long-chain n-3 fatty acid status in Cree undergoing dietary transition. British journal of nutrition. 2009;102(6):888-94.
51. Kaul N, Kreml R, Austria JA, Richard MN, Edel AL, Dibrov E, et al. A comparison of fish oil, flaxseed oil and hempseed oil supplementation on selected parameters of cardiovascular health in healthy volunteers. J Am Coll Nutr. 2008;27(1):51-8.
52. Mandasescu S, Mocanu V, Dascalita AM, Haliga R, Nestian I, Stitt PA, et al. Flaxseed supplementation in hyperlipidemic patients. Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi. 2005;109(3):502-6.
53. Patade A, Devareddy L, Lucas EA, Korlagunta K, Daggy BP, Arjmandi BH. Flaxseed reduces total and LDL cholesterol concentrations in Native American postmenopausal women. Journal of women’s health (2002). 2008;17(3):355-66.
54. Torkan M, Hassan Entezari M, Siavash M. Effect of flaxseed on blood lipid level in hyperlipidemic patients. Reviews on recent clinical trials. 2015;10(1):61-7.
55. Zhang W, Wang X, Liu Y, Tian H, Flickinger B, Empie MW, et al. Dietary flaxseed lignan extract lowers plasma cholesterol and glucose concentrations in hypercholesterolaemic subjects. British Journal of Nutrition. 2008;99(6):1301-9.
56. Paschos GK, Zampelas A, Panagiotakos DB, Katsiougiannis S, Griffin BA, Votteas V, et al. Effects of flaxseed oil supplementation on plasma adiponectin levels in dyslipidemic men. European journal of nutrition. 2007;46(6):315-20.
57. Bloedon LT, Balikai S, Chittams J, Cunnane SC, Berlin JA, Rader DJ, et al. Flaxseed and cardiovascular risk factors: results from a double blind, randomized, controlled clinical trial. J Am Coll Nutr. 2008;27(1):65-74.
58. Singh K, Mridula D, Rehal J, Barnwal P. Flaxseed: a potential source of food, feed and fiber. Critical reviews in food science and nutrition. 2011;51(3):210-22.
59. Shimano H, Yahagi N, Amemiya-Kudo M, Hasty AH, Osuga J, Tamura Y, et al. Sterol regulatory element-binding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme genes. The Journal of biological chemistry. 1999;274(50):35832-9.
60. Brown L, Rosner B, Willett WW, Sacks FM. Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr. 1999;69(1):30-42.